AptaBio Therapeutics Inc.

AptaBio Therapeutics Inc.

Share · KR7293780003 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AptaBio Therapeutics Inc.
No Price
Closing Price XKOS 29.04.2026: 8.320,00 KRW
29.04.2026 06:30
Current Prices from AptaBio Therapeutics Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
293780.KQ
KRW
29.04.2026 06:30
8.320,00 KRW
20,00 KRW
+0,24 %
Share Float & Liquidity
Free Float 69,90 %
Shares Float 18,79 M
Shares Outstanding 26,88 M
Invested Funds

The following funds have invested in AptaBio Therapeutics Inc.:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
98,16
Percentage (%)
0,10 %
Company Profile for AptaBio Therapeutics Inc. Share
AptaBio Therapeutics Inc. discovers and develops selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent for transfecting DNA or RNA into eukaryotic cells. Its product candidates include PX-115 for treating diabetic nephropathy; APX-1004 to treat diabetic retinopathy; and APX-311 for use in treating non-alcoholic steatohepatitis (NASH). The company was founded in 2009 and is based in Yongin-Si, South Korea.

Company Data

Name AptaBio Therapeutics Inc.
Company AptaBio Therapeutics Inc.
Website http://www.aptabio.com
Primary Exchange XKOS KOSDAQ
ISIN KR7293780003
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Jin Lee Soo
Market Capitalization 223 Mrd.
Country South Korea
Currency KRW
Employees 0,0 T
Address Tower 504, 13, 16954 Yongin-si
IPO Date 2019-06-12
Dividends from 'AptaBio Therapeutics Inc.'
Ex-Date Dividend per Share
15.03.2022 0,29 KRW

Stock Splits

Date Split
24.08.2021 2:1

Ticker Symbols

Name Symbol
KOSDAQ 293780.KQ
More Shares
Investors who hold AptaBio Therapeutics Inc. also have the following shares in their portfolio:
CHENGDU PUTIAN TEL. H YC1
CHENGDU PUTIAN TEL. H YC1 Share
Norddeutsche Landesbank -GZ- EO-IHS 24(28)
Norddeutsche Landesbank -GZ- EO-IHS 24(28) Unbekannt